TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/30/24 20:37 | 1/26/24 | LPTX | Leap Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Onsi Douglas E | MA | DO | CEO,CFO, | M.d | 0 | 0.00 | 0 | 8 | 2 | 488 | D | ||||||||||||||
3/21/23 16:05 | 3/17/23 | LPTX | Leap Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Onsi Douglas E | MA | DO | CEO,CFO, | M.d | 0 | 0.00 | 0 | 661 | 16 | 4,806 | D | ||||||||||||||
2/5/19 16:22 | 2/5/19 | LPTX | Leap Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Onsi Douglas E | MA | OT | CFO,GC,T | P.d | 1,000 | 1.75 | 0 | 571 | 15 | 4,459 | I | ||||||||||||||
11/16/17 13:45 | 11/14/17 | LPTX | Leap Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Onsi Douglas E | MA | OT | CFO,GC,T | P.d | 6,437 | 6.09 | 0 | 1,058 | 37 | 3,917 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |